Athos Therapeutics, Inc.

CIK 1885079 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Athos Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
May 15, 2026D0001885079-26-000001
Feb 6, 2024D0001885079-24-000002
Nov 17, 2021D/A0001885079-21-000003
Sep 28, 2021D0001885079-21-000002